Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 13:10:20499361231198335.
doi: 10.1177/20499361231198335. eCollection 2023 Jan-Dec.

Long-COVID-19 clinical and health outcomes: an umbrella review

Hu Li  1 , Jin Xia  2 , Dimitri Bennett  2   3 , Fatima Roque  4 , Rujuta A Bam  5 , Ana Bárbara Tadeu Tavares  4 , Mugdha Gokhale  6   7 , Fidelia Ida  8 , Jinnie Jiwon Rhee  9 , Montse Soriano Gabarro  10 , Yiqing Song  11
Affiliations
Review

Long-COVID-19 clinical and health outcomes: an umbrella review

Hu Li et al. Ther Adv Infect Dis. .

Abstract

Background: A growing interest in long-term sequelae of COVID-19 has prompted several systematic literature reviews (SLRs) to evaluate long-COVID-19 effects. However, many of these reviews lack in-depth information on the timing, duration, and severity of these conditions.

Objectives: Our aim was to synthesize both qualitative and quantitative evidence on prevalence and outcomes of long-term effect of COVID-19 through an umbrella review.

Design: Umbrella review of relevant SLRs on long-COVID-19 in terms of prolonged symptoms and clinical conditions, and comprehensively synthesized the latest existing evidence.

Data sources and methods: We systematically identified and appraised prior systematic reviews/meta-analyses using MEDLINE, Embase, and Cochrane database of systematic review from 2020 to 2021 following the preferred reporting items for systematic reviews and meta-analyses guidance. We summarized and categorized all relevant clinical symptoms and outcomes in adults with COVID-19 using the Medical Dictionary for Regulatory Activities System Organ Class (MedDRA SOC).

Results: We identified 967 systematic reviews/meta-analyses; 36 were retained for final data extraction. The most prevalent SOC were social circumstances (40%), blood and lymphatic system disorders (39%), and metabolism and nutrition disorder (38%). The most frequently reported SOC outcomes within each MedDRA category were poor quality of life (59%), wheezing and dyspnea (19-49%), fatigue (30-64%), chest pain (16%), decreased or loss of appetite (14-17%), abdominal discomfort or digestive disorder (12-18%), arthralgia with or without myalgia (16-24%), paresthesia (27%) and hair loss (14-25%), and hearing loss or tinnitus (15%).

Conclusion: This study confirmed a high prevalence of several long COVID-19 outcomes according to the MedDRA categories and indicated that the majority of evidence was rated as moderate to low.

Registration: The review was registered at PROSPERO (https://www.crd.york.ac.uk/prospero/) (CRD42022303557).

Keywords: MedDRA system organ classes; clinical outcomes; long COVID-19; prevalence; umbrella review.

PubMed Disclaimer

Conflict of interest statement

The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: DB and JX are employees of Takeda. FI is an employee of CSL Behring LLC. MSG is an employee of Bayer AG. MG is a full-time employee of Merck. HL and RAB are employees of Gilead Sciences Inc. ABTT was funded by the Grant CENTRO-04-3559-FSE-000162 within the European Social Fund (ESF). All other authors report no conflict of interest.

Figures

Figure 1.
Figure 1.
Preferred reporting items for systematic reviews and meta-analyses flow diagram. *Other publication types include case report, case studies, editorial, comment, historical article, and conference abstract.
Figure 2.
Figure 2.
(a) Prevalence of outcomes by MedDRA SOC by time at assessment: Overall. (b) Prevalence of MedDRA SOC by time at assessment and severity of COVID-19 among hospitalized patients. (c) Prevalence of MedDRA SOC by time at assessment and severity of COVID-19 among non-hospitalized patients. MedDRA SOC, medical dictionary for regulatory activities system organ class.
Figure 3.
Figure 3.
(a) Meta-analysis results of prevalence estimates of conditions within MedDRA SOC: cardiac disorders. (b) Meta-analysis results of prevalence estimates of conditions within MedDRA SOC: psychiatric disorders. (c) Meta-analysis results of prevalence estimates of conditions within MedDRA SOC: fatigue. MedDRA SOC, medical dictionary for regulatory activities system organ class; PTSD, Post-traumatic stress disorder. *Fernandez-de-Las-Penas_1: hospitalized patients; Fernandez-de-Las_Penas_2: non-hospitalized patients.
Figure 4.
Figure 4.
Quality assessment using the AMSTAR 2 tool.
See this image and copyright information in PMC

References

    1. Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr Clin Res Rev 2021; 15: 869–875. - PMC - PubMed
    1. Gao Z, Xu Y, Sun C, et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol 2021; 54: 12–16. - PMC - PubMed
    1. Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health 2021; 6: e005427. - PMC - PubMed
    1. World Health Organization. Health emergency dashboard, https://covid19.who.int/ (2021, accessed May 2022).
    1. Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK, https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/... (2021, accessed January 2023).

LinkOut - more resources